Agree To Buy Palantir Technologies At $65, Earn 17.7% Using Options

Palantir (PLTR) is trading at $130.83 while a December 2028 $65 put is being discussed as a sell for an annualized premium of 6.2%; assignment would require a 50.3% share-price decline, producing an effective cost basis of $53.50 per share. The note highlights a trailing-12-month volatility of 63% and intraday S&P 500 options flow showing 1.33M puts and 1.33M calls (put:call 0.73 vs long-term median 0.65), signaling relatively elevated put demand versus historical norms.

Analysis

Market structure: The $65 Dec‑2028 put trade primarily benefits option sellers/insurance-writers (6.2% annualized yield) and exchange/market‑making liquidity providers (NDAQ). It transfers downside risk to sellers who effectively offer conditional ownership at $53.50 net; elevated put:call (0.73 vs median 0.65) signals greater demand for downside protection and a steeper put skew, pushing PLTR implied vol and bid/ask spreads wider relative to realized vol (63% TTM).

Risk assessment: Tail scenarios include a >50% drawdown (assignment at $65), loss of large govt contracts, or a material data/privacy regulatory action — each could crater revenue and force multiple compression. In days–weeks expect IV spikes around earnings/announcements; over months the volatility premium will mean‑revert if fundamentals hold. Hidden risks: concentrated revenue, large holder/lockup dynamics, and liquidity risk in long‑dated OTM contracts.

Trade implications: For investors willing to own PLTR, selling the Dec‑2028 $65 put is a way to target a $53.50 entry, but only size to 1–3% of portfolio and cap downside with a long $40 put (put‑spread) to limit loss to ~$13.50/share. If unwilling to be assigned, prefer long protection: buy 6–12 month put spreads (e.g., $120/$80) to hedge a 30–40% drop at controlled cost. Consider relative value: long PLTR equity vs short QQQ (0.4x) to isolate idiosyncratic upside from AI re‑rating.

Contrarian angles: The market underestimates assignment/friction costs — 6.2% pa is thin against 63% vol and long tail risk; sellers are being paid little unless IV > realized by 10–20%. Historical parallels (forced assignment in volatile names) show put sellers can be stuck during rallies or left with concentrated positions during liquidity droughts. Only sell long‑dated puts when IV skew provides a clear cushion (premium >10% pa or IV > realized by >=10%).

Key Decisions for Investors

• Sell Dec‑2028 PLTR $65 put sized to 1–3% of portfolio only if comfortable being assigned at $53.50; simultaneously buy Dec‑2028 $40 put to create a $25 wide put‑spread—this caps downside to ~$13.50/share and limits max loss. Exit or roll if PLTR trades below $65 for >30 trading days or if net cost to roll exceeds 15% of notional.
• If bullish on PLTR but not on conditional ownership, accumulate shares on weakness: add to a 1–2% position on a pullback to $100, and add another tranche at $80; set a 12‑month target of +30–50% and a stop‑loss at -30% from entry price.
• If using options for hedge only, buy a 6–12 month put spread sized to 1–3% notional (example: buy $120 / sell $80 puts) to protect against a 30–40% downside at a controlled premium; reassess post‑earnings or on any major contract news within 90 days.
• Pair trade: Go long PLTR equity (1% notional) and short QQQ at 0.4x exposure to isolate Palantir idiosyncratic upside; trim if PLTR/QQQ ratio outperforms by +25% or if NASDAQ breadth deteriorates (new lows >20% of components in a month).
• Monitor next 90 days for: (a) material contract announcements or cancellations, (b) quarterly earnings vs guidance — cut exposure if revenue guidance misses by >5%, and (c) insider/13F activity showing >5% net selling by institutions before increasing allocation.